loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations
Open ICICI 3-in-1 Account

Inventurus Knowledge Solutions Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Inventurus Knowledge Solutions Ltd. 14 May 2026 11:26 AM
Result PDF

Q4FY26 & FY26 Result Announced for Inventurus Knowledge Solutions Ltd.

Healthcare Services company Inventurus Knowledge Solutions announced Q4FY26 & FY26 results

Consolidated Financial Highlights:

  • Revenue from Operations for Q4FY26 stood at Rs 8,576.52 million, an increase of 18.47% YoY compared to Rs 7,239.56 million in Q4FY25 and a growth of 5.24% QoQ from Rs 8,149.50 million in Q3FY26.
  • Total Income for the quarter was Rs 8,625.25 million, registering a growth of 18.61% YoY from Rs 7,272.17 million and a growth of 5.12% QoQ from Rs 8,205.03 million.
  • Profit before tax (PBT) for Q4FY26 reached Rs 2,529.55 million, marking an increase of 40.46% YoY compared to Rs 1,800.85 million and 10.28% QoQ over Rs 2,293.70 million.
  • Profit for the period (PAT) for Q4FY26 was Rs 2,059.68 million, reflecting an increase of 39.35% YoY from Rs 1,478.02 million and a growth of 12.35% QoQ from Rs 1,833.28 million.
  • For FY26, Consolidated Revenue from Operations was Rs 31,937.88 million, up 19.89% from Rs 26,639.94 million in FY25.
  • Annual Consolidated Profit for the period (PAT) for FY26 stood at Rs 7,215.54 million, a significant growth of 48.45% compared to Rs 4,860.59 million in FY25.

Standalone Financial Highlights:

  • Revenue from Operations for Q4FY26 was Rs 4,126.91 million, up 42.13% YoY from Rs 2,903.67 million and up 2.27% QoQ from Rs 4,035.28 million.
  • Total Income for the quarter stood at Rs 4,141.44 million, an increase of 41.80% YoY compared to Rs 2,920.59 million and a growth of 2.15% QoQ from Rs 4,054.09 million.
  • Profit before tax (PBT) for Q4FY26 reached Rs 1,983.50 million, reflecting a YoY growth of 64.17% from Rs 1,208.16 million and a QoQ growth of 7.29% from Rs 1,848.69 million.
  • Profit for the period (PAT) for the quarter was Rs 1,690.05 million, increasing by 69.32% YoY from Rs 998.11 million and 15.57% QoQ from Rs 1,462.40 million.
  • For FY26, Standalone Revenue from Operations was Rs 14,913.79 million compared to Rs 9,730.83 million in FY25.
  • Annual Standalone Profit for the period for FY26 reached Rs 5,665.19 million, representing a growth of 70.66% over Rs 3,319.48 million in FY25.

Business Highlights:

  • Segment Performance: The Group operates in a single reportable business segment, which is a Care enablement platform providing technology-enabled solutions to Healthcare providers.
  • Acquisition of TruBridge, Inc.: Inventurus Knowledge Solutions, Inc., a wholly-owned subsidiary, entered into a definitive agreement on April 23, 2026, to acquire TruBridge, Inc. (a US-based provider of healthcare technology solutions) for an enterprise value of up to USD 565 million.
  • Acquisition of Arai Solutions Private Limited: The Company approved the acquisition of 100% share capital of Arai Solutions Private Limited for a total cash consideration of Rs 11,00,00,000 (Indian Rupees Eleven crore only). The target entity provides AI-focused consultancy services and software development in the healthcare space.
  • Arai Solutions Private Limited Financials: For FY26, the target entity recorded Revenue from operations of Rs 5,462,600 and Total income of Rs 5,538,394, with a Net worth of Rs 956,433.
  • Foreign Exchange Gains: The consolidated results for FY26 included a net foreign exchange gain of Rs 627.47 million, while the standalone results recorded a net gain of Rs 447.32 million. These gains primarily relate to exchange differences arising on the realization and restatement of foreign currency denominated trade receivables and cash and bank balances.
  • Management Changes: Following a review of internal roles, Mr. Saransh Mundra will no longer be classified as Senior Management Personnel effective May 14, 2026, but will remain an integral part of the organization responsible for investor relations.
  • Associate Incorporation: The consolidated financial results from the quarter ended September 30, 2025, include the share of profit/loss from IKS WWMG MSO, LLC, an associate company.
  • Employee Stock Options: During FY26, the Company allotted 4,72,514 shares to eligible employees on the exercise of stock options under the IKS Health-ESOP Policy 2022. Additionally, the Company granted a total of 40,66,500 stock options to employees during the year.

Sachin K. Gupta, Founder & CEO, IKS Health, said: “Our performance this fiscal year underscores the deep value we bring to clinician enterprises as they navigate an increasingly complex US healthcare landscape. Ending the year with a strong 20% YoY revenue growth in FY26 is a testament to the scalability of our care enablement platform.”

“Our 'AI Human' model is now the industry standard for sustainable growth, as proven by our expanding partnerships with top-tier health systems. By deploying autonomous engines and agentic AI like MyCareHub™, we are providing the clinical and financial intelligence needed to transform care delivery. We enter FY27 with the financial strength to accelerate this AI-driven momentum.”

Nithya Balasubramanian, CFO, IKS Health, said: “Our fiscal year concluded with exceptional operational discipline, reflected in our 38% YoY EBITDA growth and significant margin expansion. The 48% rise in PAT for the year demonstrates our ability to scale efficiently and deliver profitable growth through a resilient business model which leverages the latest technology and global delivery. With a strong balance sheet and robust cash flow generation, we are well-positioned to continue investing in our technology platform to drive long-term, sustainable value for our shareholders.”

Result PDF

Result PDF

Healthcare Services company Inventurus Knowledge Solutions announced Q3FY26 results

  • Revenue: Rs 8,150 million against Rs 6,572 million during Q3FY25, change 24%.
  • EBITDA: Rs 2,816 million against Rs 2,006 million during Q3FY25, change 40%.
  • PAT: Rs 1,833 million against Rs 1,297 million during Q3FY25, change 41%.

Sachin K. Gupta, Founder & Global CEO, IKS Health: "Our strong Q3 performance, characterized by 24% revenue growth, validatesthat our Care Enablement Platform is the critical solution for a US healthcare market facing a perfect storm of cost, quality, and access pressures. As physician marginsface renewed compression from stagnant reimbursement rates, we are seeing this act as a powerful catalyst for increased outsourcing and platform adoption. We continue to deepen our value proposition by advancing our AI capabilities—specifically moving our Patient Engagement suite toward multi-agent orchestration—to drive cognitive reasoning and independent action. Our recent wins with partners like StrideCare and VitalMD demonstrate that provider enterprises are increasingly choosing our integrated platform to ensure their financial sustainability and clinical efficiency."

Nithya Balasubramanian, Group CFO, IKS Health, said: “Our Q3FY26 performance underscores our consistent ability to drive profitable growth and deliver significant value to our clients. We achieved a 24% YoY revenue increase and a 41% growth in Profit After Tax (PAT), fueled by continuous expansion across existing and new client relationships. Margin expansion is a direct result of our successful operating leverage, technology deployment and focused cost management. ”

Result PDF

Healthcare Services company Inventurus Knowledge Solutions announced Q2FY26 results

  • Revenue: Rs 7,811 million compared to Rs 6,428 million during Q2FY25, change 22%.
  • EBITDA: Rs 2,718 million compared to Rs 1,898 million during Q2FY25, change 43%.
  • PAT: Rs 1,807 million compared to Rs 1,130 million during Q2FY25, change 60%.

Sachin K. Gupta, Founder & Global CEO, IKS Health, said: “The second quarter was a period of significant strategic execution and strong financial performance for IKS Health. Our results underscore the growing market demand for our Care Enablement Platform as health systems increasingly recognize the need to holistically address administrative, clinical, and financial challenges.”

“A key highlight of this quarter was the launch of our Agentic AI platform on Google Cloud and native integration of Scribble Now, our ambient AI scribing solution, into revenue cycle management, coding, and clinical documentation workflows, creating the industry’s first connected encounter-to-reimbursement platform and winning the 2025 Dora Award from Google Cloud Award for ‘Augmenting Human Expertise with AI’. We have also significantly accelerated the execution of our AI strategy, marked by the appointment of our new Chief AI Officer. These accomplishments reflect our unwavering commitment to augmenting human expertise to deliver unparalleled clinical, financial, and operational excellence to our clients."

Nithya Balasubramanian, Group CFO, IKS Health said: “IKS Health’s strong Q2FY26 financial performance, highlighted by a 22% YoY Revenue, 43% EBITDA and 60% PAT growth reflects our continued focus on driving consistent, profitable growth. The improvement in our EBITDA margin showcases the scalability of our platform and disciplined capital management. As we progress, we will maintain this balanced approach—preserving margin strength while investing strategically to support sustainable growth and long-term shareholder value.”

Result PDF

Healthcare Services company Inventurus Knowledge Solutions announced Q1FY26 results

  • Revenue at Rs 7,401 million (15.6% YoY / 2.2% QoQ growth).
  • EBITDA at Rs 2,378 million at 32.1% of revenue (36.3% YoY / 5.1% QoQ growth).
  • PAT at Rs 1,515 million at 20.5% of revenue (58.7% YoY / 2.5% QoQ growth)
  • Adjusted PAT at Rs 1,682 million at 22.7% of revenue (51.4% YoY / 2.2% QoQ growth).

Sachin K. Gupta, Founder & Global CEO, IKS Health, said: “Our performance this quarter reflects the continued momentum in our business and the stickiness of our integrated tech-led care enablement platform built on strong client relationships, scalable solutions, and disciplined execution.”

“The sustained revenue growth at 16% and improvement of EBITDA margin for the combined entity to 32% demonstrates the impact of our technology-led care enablement platform and global delivery capabilities. As we move forward, our focus remains on deepening client value, investing in innovation, and scaling our platform to address the evolving needs of the healthcare ecosystem.”

Nithya Balasubramanian, CFO, IKS Health said: “We delivered a strong financial performance in Q1FY26, driven by consistent revenue growth and continued focus on operational efficiency. Our EBITDA margin improvement reflects disciplined cost management, scalability of our platform, and prudent capital allocation. As we move ahead, we remain committed to sustaining healthy margins while strategically investing in capabilities that drive long-term value creation.”

Result PDF

Healthcare Services company Inventurus Knowledge Solutions announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • Revenue growth in Q4, 17% YoY in INR, 13% YoY in USD
  • Q4 EBITDA up 68% YoY; 13% QoQ
  • PAT up 133% growth YoY; 14% QoQ
  • Adjusted PAT up 108% YoY; 13% QoQ
  • Revenue:  7,240 million
  • PAT: Rs 1,478 million
  • EBITDA: Rs 2,262 million
  • Adjusted PAT: Rs 1,646 million

FY25 Financial Highlights:

  • Revenue at Rs 26,640 million (47% YoY)
  • EBITDA at Rs 7,911 million (50% YoY)
  • PAT at Rs 4,861 million (31% YoY) 
  • Adjusted PAT at Rs 5,504 (39% YoY)

Sachin K. Gupta, Founder & CEO, IKS Health. said, “The results for the quarter reflect the strength of our business where we have delivered industry leading revenue growth owing to ramp up of new clients and continuous margin improvement as we continue to transform the business using technology and global human capital. Our Q4FY25 EBITDA margins have crossed 31%, a significant improvement from the 24% proforma margin of FY24,”

 “The last quarter saw five prominent client wins including three platform deals which gives us the confidence in our strategy of building the full breadth of our platform in a market that largely consists of point solutions companies.”

Nithya Balasubramanian, CFO, IKS Health said, “We have delivered a very healthy margin and strong revenue growth of 17% YoY and 10% QoQ despite some compression in revenue as we focus on the right set of customers and globalize the legacy AQuity workforce. Ongoing investments in technology and AI will remain central to our strategy for achieving excellence in outcomes and client satisfaction.”

Result PDF

Healthcare Services company Inventurus Knowledge Solutions announced Q3FY25 results

  • Revenue at Rs 6,572 million (15.9% YoY / 2.2% QoQ growth).
  • EBITDA at Rs 2,006 million at 30.5% of revenue (24.3% YoY / 5.7% QoQ growth).
  • PAT at Rs 1,297 million at 19.7% of revenue (27.7% YoY / 14.8% QoQ growth).
  • Adjusted PAT at Rs 1,455 million at 22.1% of revenue (30.6% YoY / 12.8% QoQ growth).

Sachin K. Gupta, Founder and Chief Executive Officer, IKS Health, said: “We continue our journey of improving profitability by transforming legacy AQuity’s operating model through technology and global human capital. EBITDA margins have crossed 30% this quarter, a significant improvement from the 24% proforma margin of FY24. With revenue from our top five customers growing 19% and new client acquisitions ramping up, we are optimistic about sustained growth heading into the final quarter and the next financial year.”

Nithya Balasubramanian, Chief Financial Officer, IKS Health, said: “We are steadily regaining our legacy IKS EBITDA margins. PAT growth has outpaced EBITDA growth due to lower finance costs as we continue to repay our debt. Adjusted PAT, excluding non-cash amortization of acquired intangibles, has improved by 31%. We will maintain our investments in technology and AI to drive superior outcomes and enhance customer satisfaction.”

Result PDF

Trending News

Tata Motors Passenger Vehicles has unveiled the next-generation Tiago and Tiago.ev hatchbacks

Tata Motors Passenger Vehicles has unveiled the next-generation Tiago and Tiago.ev hatchbacks

Published on 29-May-2026 09:22

JSW Steel has informed the exchanges that the company has commenced work on its fully owned greenfield integrated steel plant project at Paradeep

JSW Steel has informed the exchanges that the company has commenced work on its fully owned greenfield integrated steel plant project at Paradeep

Published on 29-May-2026 09:21

India's defence manufacturing sector received a major boost as the Defence Ministry invited bids from Tata Advanced Systems

India's defence manufacturing sector received a major boost as the Defence Ministry invited bids from Tata Advanced Systems

Published on 29-May-2026 09:19

Persistent Systems, through its subsidiary PerSys Estonia OÜ, has signed an agreement to acquire part of the business of Estonia-based Concise Systems OÜ

Persistent Systems, through its subsidiary PerSys Estonia OÜ, has signed an agreement to acquire part of the business of Estonia-based Concise Systems OÜ

Published on 29-May-2026 09:16

Royal Enfield has launched the new Bullet 650 in India at an ex-showroom price of ~ ₹3.65 lakh

Royal Enfield has launched the new Bullet 650 in India at an ex-showroom price of ~ ₹3.65 lakh

Published on 29-May-2026 09:16

Graphite India reported a healthy performance in Q4FY26

Graphite India reported a healthy performance in Q4FY26

Published on 29-May-2026 09:14

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app